(Washington Post) May 18, 2019 - Compared with other cancer success stories, the disease historically has had a shortage of good news. Until recently, it hasn’t benefited from new treatments for decades.
For the past few years, as part of the University of Chicago Pritzker medical school obstetrics-gynecology rotation, med students...
(The Street) May 15, 2019 - Shares of ImmunoGen plunge after the U.S. Food and Drug Administration requests additional trials to 'evaluate the safety and efficacy' of one of its cancer-fighting treatments.
ImmunoGen said in statement that it had requested a meeting with FDA officials to discuss the results of its Phase 3 FORWARD I...